Skip Navigation


Human Molecular Genetics Advance Access originally published online on August 2, 2008
Human Molecular Genetics 2008 17(21):3318-3331; doi:10.1093/hmg/ddn227
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
17/21/3318    most recent
ddn227v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Nyholt, D. R.
Right arrow Articles by Palotie, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nyholt, D. R.
Right arrow Articles by Palotie, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

A high-density association screen of 155 ion transport genes for involvement with common migraine

Dale R. Nyholt1,*, K. Steven LaForge2,3,{dagger}, Mikko Kallela4, Kirsi Alakurtti3, Verneri Anttila3, Markus Färkkilä4, Eija Hämaläinen3,5, Jaakko Kaprio6,7, Mari A. Kaunisto3,5,8, Andrew C. Heath9, Grant W. Montgomery10, Hartmut Göbel11, Unda Todt12, Michel D. Ferrari13, Lenore J. Launer14, Rune R. Frants15, Gisela M. Terwindt13, Boukje de Vries15, W.M. Monique Verschuren16, Jan Brand17, Tobias Freilinger18, Volker Pfaffenrath19, Andreas Straube18, Dennis G. Ballinger20, Yiping Zhan20,{ddagger}, Mark J. Daly21, David R. Cox20, Martin Dichgans18, Arn M.J.M. van den Maagdenberg13,15, Christian Kubisch12, Nicholas G. Martin1, Maija Wessman3,5,8, Leena Peltonen21,22,23,24 and Aarno Palotie3,8,21,24

1 Genetic Epidemiology Laboratory, Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Brisbane 4029, Queensland, Australia 2 Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY 10065, USA 3 Biomedicum Helsinki, Research Program in Molecular Medicine and Departments of Clinical Chemistry and Medical Genetics 4 Department of Neurology, Helsinki University Central Hospital 5 The Finnish Institute for Molecular Medicine, Finnish Genome Centre 6 Department of Public Health, University of Helsinki, Helsinki 00014, Finland 7 Department of Mental Health and Alcohol Research, National Public Health Institute, Helsinki 00300, Finland 8 Folkhälsan Research Centrum, Helsinki 00014, Finland 9 Department of Psychiatry, Washington University School of Medicine, St Louis, MO 63110, USA 10 Molecular Epidemiology Laboratory, Queensland Institute of Medical Research, Brisbane 4006, Queensland, Australia 11 Kiel Pain and Headache Centre, Kiel 24149, Germany 12 Institute of Human Genetics, Institute for Genetics and Center for Molecular Medicine Cologne, University of Cologne, Cologne 50923, Germany 13 Department of Neurology, Leiden University Medical Centre, Leiden 2300, RC, The Netherlands 14 Intramural Research Program (IRP), National Institute on Aging (NIA), National Institutes of Health, 7201 Wisconsin Ave, Bethesda, Maryland, US 15 Department of Human Genetics, Leiden University Medical Centre, Leiden 2300, RC, The Netherlands 16 National Institute for Public Health and the Environment, Centre for Prevention and Health Services Research, Bilthoven 3720, BA, The Netherlands 17 Migräne- und Kopfschmerz-Klinik Königstein, Ölmühlweg 31, 61462 Königstein im Taunus, Germany 18 Department of Neurology, Ludwig-Maximilians-University Munich, Klinikum Grosshadern, Marchioninistr, Munich 81377, Germany 19 Neurologische Gemeinschaftspraxis Leopoldstraße, Munich 81377, Germany 20 Perlegen Sciences Inc., Mountain View, CA 94043 21 Broad Institute of MIT and Harvard, Cambridge, MA 02141-2023, USA 22 Department of Molecular Medicine, National Public Health Institute, The Finnish Institute for Molecular Medicine 23 Department of Medical Genetics, University of Helsinki, Helsinki 00014, Finland 24 The Wellcome Trust Sanger Institute, Cambridge CB10 1HH, UK

* To whom correspondence should be addressed. Tel: +61 733620258; Fax: +61 733620101; Email: dale.nyholt{at}qimr.edu.au

Received June 6, 2008; Revised July 21, 2008; Accepted July 31, 2008

The clinical overlap between monogenic Familial Hemiplegic Migraine (FHM) and common migraine subtypes, and the fact that all three FHM genes are involved in the transport of ions, suggest that ion transport genes may underlie susceptibility to common forms of migraine. To test this leading hypothesis, we examined common variation in 155 ion transport genes using 5257 single nucleotide polymorphisms (SNPs) in a Finnish sample of 841 unrelated migraine with aura cases and 884 unrelated non-migraine controls. The top signals were then tested for replication in four independent migraine case–control samples from the Netherlands, Germany and Australia, totalling 2835 unrelated migraine cases and 2740 unrelated controls. SNPs within 12 genes (KCNB2, KCNQ3, CLIC5, ATP2C2, CACNA1E, CACNB2, KCNE2, KCNK12, KCNK2, KCNS3, SCN5A and SCN9A) with promising nominal association (0.00041 < P < 0.005) in the Finnish sample were selected for replication. Although no variant remained significant after adjusting for multiple testing nor produced consistent evidence for association across all cohorts, a significant epistatic interaction between KCNB2 SNP rs1431656 (chromosome 8q13.3) and CACNB2 SNP rs7076100 (chromosome 10p12.33) (pointwise P = 0.00002; global P = 0.02) was observed in the Finnish case–control sample. We conclude that common variants of moderate effect size in ion transport genes do not play a major role in susceptibility to common migraine within these European populations, although there is some evidence for epistatic interaction between potassium and calcium channel genes, KCNB2 and CACNB2. Multiple rare variants or trans-regulatory elements of these genes are not ruled out.


{dagger} Deceased.

{ddagger} Present address: Affymetrix Inc., Santa Clara, CA 95051, USA.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.